Mindray Medical is set to penetrate the medtech market

Mindray Medical created a strong name in a wide array of medical devices and consumables. It is further complementing ...

June 4, 2013 | Tuesday | Analysis
Sino Biopharma banks on quality manufacturing

Sino Biopharmaceutical, an integrated name in R&D, manufacturing and marketing of health enhancing modernized Chin...

June 4, 2013 | Tuesday | Analysis
Matt Kerr: Tough task ahead for APAC HR managers

With rapid growth of life sciences industry in Asia, we have seen many success stories over the last decade. However, an...

June 12, 2013 | Wednesday | Opinion
China Resources Sanjiu looks ahead at acquisitions for growth

To enhance its market opportunities and drive business growth, China Resources Sanjiu Medical & Pharmaceutical is ...

June 4, 2013 | Tuesday | Analysis
United Labs boosts production to meet high demand

The global life science industry has been facing a financial crunch and The United Laboratories too has felt the jolt....

June 4, 2013 | Tuesday | Analysis
Top 5 healthcare trends

Singapore: The healthcare industry is at a disruptive stage globally and patient's involvement and engagement in their o...

November 20, 2014 | Thursday | Opinion
North China Pharma integrates R&D strength in its system

North China Pharmaceutical Company (NCPC) faced a decline of around 26 percent in 2012. The company is principally eng...

June 3, 2013 | Monday | Analysis
Asia faces an acute skills gap challenge

Shortage of skills and qualification among life science professionals to pursue risk laden activities is proving to be a...

June 12, 2013 | Wednesday | Analysis
Mindray goes on acquisition spree for strong portfolio

Mindray Medical International is emerging as a global name in the medical devices industry, marking 25 percent growth in...

June 22, 2012 | Friday | Analysis
Resmed dominates the niche sleep disorder market

A distinguished name in treating, diagnosing and managing sleep-disordered breathing (SDB) and other respiratory disor...

June 4, 2013 | Tuesday | Analysis
Sinopharm demonstrates king size growth, yet again

Sinopharm, a dominant name in the distribution of pharmaceutical and healthcare products in China, continues to grab a...

May 31, 2013 | Friday | Analysis
Cipla nurtures global vision for affordable drugs

The king of generics, Cipla, has been aggressive in expanding product portfolio and reaching out to international market...

June 13, 2012 | Wednesday | Analysis
Asia bioscience grows 11 percent, crosses $150 bn

During the year 2012, the bioscience industry in the Asia Pacific region clocked $154.40 billion in revenues, recording ...

June 21, 2013 | Friday | Analysis
Dr. Reddy's makes a mark in the US generics market

Striking profit on a high note, Dr. Reddy's crossed $1.5 billion worth of business in 2012, marking a growth of 22 per...

June 4, 2013 | Tuesday | Analysis
Aurobindo Pharma revamps strategy to accelerate growth

Aurobindo Pharma, ranked among the top pharmaceutical company in India, clocked $1 billion revenue in 2012. Aurobindo ...

June 4, 2013 | Tuesday | Analysis
ResMed builds on partnerships for growth

Driving in the niche industry of sleep disorders, ResMed was aggressive in strengthening its portfolio through acquisiti...

June 14, 2012 | Thursday | Analysis
Bioscience Industry clocks $139 bn, grows 8.37%

The bioscience industry in the Asia Pacific region, in 2011, got pulled back into a low growth cycle. In a replay of 200...

July 3, 2012 | Tuesday | Analysis
Sigma Pharma leverages on its pharmacy business

Marking a strong presence of 100 years in the pharmaceutical sector in the year 2012, Sigma Pharmaceuticals retained i...

May 31, 2013 | Friday | Analysis